Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers

201854 citationsJournal Articlegreen Open Access

Authors

Nicole P. Lindsey · Centers for Disease Control and Prevention

Kalanthe Horiuchi · Centers for Disease Control and Prevention

Corey Fulton · Centers for Disease Control and Prevention

Amanda J. Panella · Centers for Disease Control and Prevention

Olga I. Kosoy · Centers for Disease Control and Prevention

Jason O. Velez · Centers for Disease Control and Prevention

Elizabeth Krow-Lucal

Abstract

Although the percentage of vaccinees with a positive PRNT and antibody titers decreased over time, a single dose of YF vaccine provided long-lasting protection in the majority of US travellers. A booster dose could be considered for certain travellers who are planning travel to a high risk area based on immune competence and time since vaccination.

Topics & Keywords

Mosquito-borne diseases and control Viral Infections and Outbreaks Research Viral Infections and Vectors

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Travel Medicine

Volume 25, Issue 1

DOI: 10.1093/jtm/tay108

Field-Weighted Citation Impact: 7.81